How to make a billion in biotech: It’s much more difficult than the software industry, but the key to biotech billions for entrepreneurs and investors seems to be taking one or only a very few highly concentrated positions in companies that they developed over years of effort. So reports Forbes Magazine, noting that only three of its 400 wealthiest Americans made most of their money by spearheading the development and marketing of a new drug.
Going hostile: Valeant Pharmaceuticals, Canada’s largest drugmaker, has made a $5.7 billion hostile takeover bid of Cephalon, a Pennsylvania-based maker of pain and sleep drugs.
To read the full, original article click on this link: How to make a billion in biotech (Morning Read)
Author:
